Nerac

Information That Drives Innovation

We’re here to help with your research needs
+1 860 872 7000
Customer Access
  • Home
  • What We Do
    • Innovation Insights and Consulting Practice
    • Regulatory
    • Medical Device and Life Sciences
    • Technology Scouting and Innovation
    • Market Research
    • Intellectual Property
    • Commercialization Services for TTOs and Start-Ups
    • Critical Updates
  • Who We Serve
  • How to Engage
  • Why Nerac?
  • Meet our Team
    • Leadership Team
    • Our Analysts
    • Our Partners
  • Nerac Insights and Publications
    • Articles
    • Case Studies
    • Press Room
    • Videos
    • Webcasts
    • White Papers
  • Contact Us
You are here: Home / Nerac Insights / Nerac Announces Addition to Analyst Team

Nerac Announces Addition to Analyst Team

Facebook0
Google+0
LinkedIn0
Twitter0

New analyst brings experience in medical devices, neuroscience and biology.

Read the full release here.

Related Posts

  • The Importance of Article Selection for Meeting the MedDev 2.7.1 Rev 3 Requirements
    58
    By Donna Mitchell-Magaldi, Nerac Analyst, On March 20, 2010, the revised Guideline; MedDev 2.7.1 Rev 3 Clinical Evaluation: A Guide for Manufacturers and Notified Bodies became a requirement for obtaining and maintaining a CE Mark for all classes of devices marketed in the European Union. An important component of the MedDev 2.7.1 Rev 3 is the…
    Tags: read, full, nerac, analyst, devices, medical
  • Are Your Devices State-of-the-Art?
    57
    By Ron Sills, Nerac Analyst Originally Published: September 29th, 2014 The European Union’s Council Directive  93/42/EEC concerning medical devices  contains the essential requirements to be met by medical device manufacturers in order to market their products in the 28 member countries.  A technical file for Class IIa and IIb devices, or a design dossier for…
    Tags: devices, medical, read, analyst, originally, nerac, published, full
  • Nerac Announces Addition to Analyst Team
    55
    New analyst brings extensive experience in the biotechnology industry, primarily in the areas of chemical and biochemical defense systems, electrochemical devices, nanotechnology, materials chemistry and physical-organic chemistry Read the full release here.
    Tags: read, analyst, devices, release, full, originally, published, team, addition, announces
  • Case Studies
  • White Papers
  • Webcasts
  • Articles
    • Nerac Strategist
    • Energy
    • Food & Nutrition
    • Intellectual Property
    • Regulatory
    • Technology & Innovation
    • Medical Device & Healthcare
    • Pharmaceutical
    • Engineering
    • Market Research
    • Critical Alerts
    • Chemistry/Advanced Materials
  • Press Room

Click here to learn more about….

3d printing advanced materials aerospace Ask Kevin Videos biotech CFDA clinical literature evaluations commercialization strategies competitive intelligence conflict minerals Disruptive Technologies emerging markets energy EU MDR FDA food Industry 4.0 innovation Inspiring Next intellectual property intellectual property strategies IP market analysis market research medical device medical devices nerac Nerac client questions Nerac Strategist notified body audit open innovation Order 650 patenting strategies patent landscape pharmaceutical Post-Market Surveillance R&D regulatory regulatory compliance Robert Beinstein Rosemarie Szostak specialty chemicals Sustainable Development Goals technology scouting XcellR8
  • Facebook
  • Google+
  • Linkedin
  • RSS
  • Twitter
  • YouTube
  • Career Opportunities

Copyright © 2021 Nerac · One Technology Drive · Tolland, CT 06084 · 1.860.872.7000

Sign Up for the Nerac Strategist

Like what you see? Sign up here to receive the Nerac Strategist newsletter, a compilation of analyst insights on rapidly developing industry issues, compliance challenges and commercial opportunities!
  • This field is for validation purposes and should be left unchanged.